Ansatte
9
Etablert
2016
Hovedkontor
Oslo
ZELLUNA IMMUNOTHERAPY AS
Zelluna Immunotherapy is an exciting and dynamic start-up based in Oslo specializing in T cell receptor (TCR) cell therapies, built around a distinctive scientific approach.
The company is developing TCR-guided natural killer (TCR-NK) cells as an allogeneic, off-the-shelf cellular therapy for patients with solid tumors.
Ingen har gjort krav på denne bedriften enda.
